Mark Chin - Apr 21, 2022 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Signature
/s/ Mark Chin
Stock symbol
PYXS
Transactions as of
Apr 21, 2022
Transactions value $
-$5,324,571
Form type
4
Date filed
4/25/2022, 12:12 PM
Previous filing
Apr 4, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Sale -$5.32M -1.75M -100% $3.05 0 Apr 21, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mark Chin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The securities were held directly by Arix Bioscience Holdings Limited ("Arix"). The Reporting Person is one of for members of the Investment Committee of Arix and, in such capacity, may be deemed to share voting and dispositive power over the securities held by Arix. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his respective pecuniary interests therein.